BUYINS.NET: Market Maker Surveillance Report. Top 6 Abnormal Price Friction Stocks For March 11, 2009

Mar 12, 2009 (M2 PRESSWIRE via COMTEX) --
OII | Quote | Chart | News | PowerRating -- BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for March 11, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This "fair market making" requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3,635 companies with "abnormal" market making, 2,936 companies with positive Friction Factors and 2,450 companies with negative Friction Factors. Here is a list of the top 6 companies with the Abnormal Price Friction (unfair market) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Express Scripts (NASDAQ: ESRX | Quote | Chart | News | PowerRating), Genzyme Corp. (NASDAQ: GENZ | Quote | Chart | News | PowerRating), Alliant Techsystems (NYSE: ATK | Quote | Chart | News | PowerRating), Emergency Medical Services (NYSE: EMS | Quote | Chart | News | PowerRating), McDonalds Corp. (NYSE: MCD | Quote | Chart | News | PowerRating) and Oceaneering International (NYSE: OII). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net.

Market Maker Friction Factor is shown in the chart below:

Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction

ESRX -$2.76 -5.81% 2,752,758 49.78% 2,665,154 48.19% 87,604 abnormal

GENZ -$2.37 -4.29% 2,831,641 52.04% 2,469,111 45.37% 362,530 abnormal

ATK -$1.88 -2.88% 189,000 35.05% 177,073 32.84% 11,927 abnormal

EMS -$1.48 -5.04% 156,406 41.20% 142,432 37.51% 13,974 abnormal

MCD -$1.42 -2.70% 6,736,600 40.53% 6,593,707 39.67% 142,893 abnormal

OII -$1.41 -4.40% 451,007 37.58% 426,425 35.54% 24,582 abnormal

Click here to view chart: http://www.buyins.com/ff/ffabnl3-11-09.jpg

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more buying than selling on Wednesday and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ESRX with 87,604 greater shares of buying than selling (NetVol) and the stock price was down -$2.76. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

Express Scripts, Inc. (NASDAQ: ESRX | Quote | Chart | News | PowerRating) offers a range of pharmacy benefit management (PBM) services in North America. The company provides retail network pharmacy management, retail drug card programs, home delivery pharmacy services, benefit design consultation, drug utilization review, drug formulary management programs, and compliance and therapy management programs. It also offers integrated PBM services that comprise network claims processing, home delivery services, benefit design consultation, drug utilization review, formulary management, and drug data analysis services. In addition, Express Scripts provides various specialty services, including patient care and direct specialty home delivery to patients; distribution of injectable drugs, pharmaceuticals, medical supplies, and pharmaceuticals to patient homes and physician offices; sponsored generic patient assistance programs; distribution of sample units to physicians; verification of practitioner licensure; fertility services to providers and patients; and bio-pharmaceutical services, including marketing, reimbursement, and customized logistics solutions. It serves health maintenance organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, and government health programs. The company was founded in 1986 and is headquartered in St. Louis, Missouri.

Genzyme Corporation (NASDAQ: GENZ | Quote | Chart | News | PowerRating) operates as a biotechnology company worldwide. The company's Genetic Diseases segment manufactures and distributes therapeutic products, including Cerezyme as an enzyme replacement therapy for the treatment of Type 1 and Type 3 Gaucher diseases; Fabrazyme, a recombinant form of the human enzyme alpha- galactosidase for the treatment of Fabry disease; Myozyme as a therapy for Pompe disease; and Aldurazyme for the treatment of Mucopolysaccharidosis I. This segment markets and sells its products directly to physicians, hospitals, treatment centers, pharmacies, and government agencies through distributors. Its Cardiometabolic and Renal segment develops, manufactures, and distributes products consisting of Renagel and Renvela for the control of serum phosphorus in patients with chronic kidney disease on dialysis; Hectorol, a line of vitamin D2 pro-hormone products for the treatment of secondary hyperparathyroidism; and Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. This segment sells its products to retail pharmacies, hospitals, and other providers of medication to patients. The company's Biosurgery segment provides biotherapeutics and biomaterial-based products, which comprise Synvisc, a biomaterial-based product that is used to treat the pain associated with osteoarthritis of the knee; and Sepra family of products to prevent adhesions following various surgical procedures in the abdomen and pelvis. Its Hematologic Oncology segment develops products for the treatment of cancer, which include Campath for the treatment of B-cell chronic lymphocytic leukemia; Clolar for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia; and Mozobil for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. The company was founded in 1981 and is based in Cambridge, Massachusetts.

Alliant Techsystems, Inc. (NYSE: ATK | Quote | Chart | News | PowerRating) supplies aerospace and defense products to the U.S. government agencies, and its prime contractors and subcontractors. The company also supplies ammunition and related accessories to law enforcement agencies and commercial customers. Its ATK Armament Systems segment offers military ammunition and gun systems, such as small-caliber training and tactical ammunition rounds; medium-caliber ammunition, including fighting and light armored vehicles, helicopters, A-10 close-combat support aircraft, and AC-130 gunship aircraft; and chain guns for medium-caliber gun systems. This segment also provides ammunition, gun care products, targets and traps, rifle scopes and mounts, and binoculars to law enforcement agencies and sport shooting enthusiasts; solid extruded propellant for medium caliber and tank ammunition, artillery charge systems, and air and ground launched rockets; and commercial gun powder for sporting ammunition manufacturers, hunters, and sport shooters. The company's ATK Launch Systems segment manufactures human and cargo space launch vehicles, conventional and strategic missiles, missile defense interceptors, and decoy and illuminating flares. Its ATK Mission Systems segment offers missile systems, precision-guided munitions, force protection systems, speed-of-light weapons, soldier weapon systems, barrier systems, large-caliber ammunition, tactical and hypersonic propulsion systems, warheads, fuzes, missile defense divert and control systems, electronic warfare and aircraft integration products, structural and engine components, radomes, and apertures; solar arrays and solar panel substrates; optical support structures; radio frequency antenna reflectors and antennas; composite bus structures, towers, and subsystems; thermal systems; deployable booms and masts; titanium propellant tanks; and insertion motors, as well as technical services. The company was founded in 1990 and is headquartered in Minneapolis, Minnesota.

Emergency Medical Services Corporation (NYSE: EMS), through its subsidiaries, provides emergency medical services in the United States. It operates in two segments, American Medical Response (AMR) and EmCare. The AMR segment provides various emergency and non-emergency ambulance transport and related services, including emergency response services; non-emergency transport services, such as inter-facility critical care transport, wheelchair and stretcher-car transports, and other inter-facility transports; and other services, including dispatch, event medical, managed transportation, paramedic training, and air ambulance services. The EmCare segment provides outsourced emergency department staffing and related management services to healthcare facilities. These services comprise contract management; staffing; recruiting; scheduling; payroll administration and benefits; customer satisfaction programs; and unbundled management services, such as billing and collection, scheduling, recruitment, risk management, and administrative services. The company offers its services to communities, hospitals, government agencies, independent physician groups, healthcare facilities, attending medical staff, and insurers. Emergency Medical Services Corporation is headquartered in Greenwood Village, Colorado.

McDonalds Corporation (NYSE: MCD), together with its subsidiaries, franchises and operates McDonalds restaurants in the food service industry worldwide. Its restaurants offer various food items, soft drinks, and coffee and other beverages. As of December 31, 2008, the company operated 31,967 restaurants in 118 countries, of which 25,465 were operated by franchisees; and 6,502 were operated by the company. McDonald's Corporation was founded in 1948 and is based in Oak Brook, Illinois.

Oceaneering International, Inc. (NYSE: OII), together with its subsidiaries, provides engineered products and services primarily to the offshore oil and gas industry. Its products and services include remotely operated vehicles, mobile offshore production systems, built-to-order specialty hardware, engineering and project management, subsea intervention services, nondestructive testing and inspection, and manned diving. The company provides engineering services and related manufacturing for various industrial requirements, including ship and submarine husbandry, search and recovery, maintenance and repair, commercial theme park equipment, and engineering services and products for the space industry. The company markets its products and services relating to oil and gas industry for companies engaging in offshore exploration, development, and production. It also offers marine services and related engineering services to government agencies, defense contractors, NASA, and NASA prime contractors; and construction, theme parks, and other industrial customers; as well as insurance companies, salvage associations, and other customers who need specialized operations in deep water. The company operates in the United States, west Africa, the United Kingdom, Norway, Brazil, and Asia. Oceaneering International was founded in 1965 and is based in Houston, Texas.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,500,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net

CONTACT: Thomas Ronk, CEO, BUYINS.NET
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Mcdonalds Corp (MCD) MCD. Mcdonalds Corp (MCD) has Short Term PowerRatings at TradingMarkets. Details on Mcdonalds Corp (MCD) Short Term PowerRatings is available at This Link.

For full details on Express Scripts Inc (ESRX) ESRX. Express Scripts Inc (ESRX) has Short Term PowerRatings at TradingMarkets. Details on Express Scripts Inc (ESRX) Short Term PowerRatings is available at This Link.

For full details on Emergency Medical Services L.P. (EMS) EMS. Emergency Medical Services L.P. (EMS) has Short Term PowerRatings at TradingMarkets. Details on Emergency Medical Services L.P. (EMS) Short Term PowerRatings is available at This Link.

For full details on Alliant Techsystems Inc (ATK) ATK. Alliant Techsystems Inc (ATK) has Short Term PowerRatings at TradingMarkets. Details on Alliant Techsystems Inc (ATK) Short Term PowerRatings is available at This Link.

For full details on Genzyme Corporation (GENZ) GENZ. Genzyme Corporation (GENZ) has Short Term PowerRatings at TradingMarkets. Details on Genzyme Corporation (GENZ) Short Term PowerRatings is available at This Link.

For full details on Oceaneering Internat (OII) OII. Oceaneering Internat (OII) has Short Term PowerRatings at TradingMarkets. Details on Oceaneering Internat (OII) Short Term PowerRatings is available at This Link.